Note: This article is a proposal based solely on the supplied video transcript and reflects Dr. Patrick Nemechek’s comments and clinical interpretations in that video. It is intended for human review and educational use only.
In this video, Dr. Patrick Nemechek discusses “long COVID” in children—symptoms that persist after the acute infectious phase has resolved. He emphasizes that, in his view, the persistence of symptoms can be substantial and should be taken seriously when evaluating a child who does not seem to “bounce back” after COVID.
He also describes a framework—referencing other work he has discussed in prior videos—in which ongoing inflammation and intestinal barrier dysfunction (“leaky gut” patterns) may be present in long COVID, and he shares a practical approach he says can help address a specific intestinal barrier pattern.
What Dr. Nemechek means by “long COVID” in kids
Dr. Nemechek distinguishes the initial, acute respiratory illness from what he calls “long COVID”: a range of symptoms that persist after the infectious part of COVID has passed. In the video, he notes that in adults, these symptoms have been observed to persist for years in some cases, and he frames pediatric long COVID as an increasingly important clinical concern.
He cites a large Italian pediatric-unit follow-up in which:
- Children diagnosed with SARS-CoV-2 were followed approximately every three months using surveys.
- The cohort included 1,129 children with diagnosed SARS-CoV-2 infection.
- He states that the majority were not hospitalized.
His summary of symptom persistence: “this doesn’t go away” for many
In Dr. Nemechek’s telling of the study results, many children reported symptoms that persisted beyond the acute infection. He states that about 68% had some symptoms that persisted after the infectious phase was gone. He then notes that long COVID is defined as symptoms lasting three months, and says that 16% of all the children had symptoms lasting three months or more.
He lists example categories of symptoms described in the follow-up data, including:
- Respiratory symptoms
- Neurological and cognitive symptoms
- Gastrointestinal symptoms such as diarrhea
- Fatigue
- Sleep disturbances
Dr. Nemechek then focuses on what he finds most concerning: the duration of symptoms reported in the study’s longer follow-up window. He describes figures extending out to 18 months and highlights that, in his summary, a large proportion of symptomatic children were still symptomatic at that point. For respiratory symptoms, he states that more than 75% still had symptoms at a year and a half. For neurological symptoms—described in the video as including issues such as “POTS, lightheadedness, can’t focus”—he characterizes persistence as high (around 85% at 18 months in his description). He similarly emphasizes that fatigue remained very common at 18 months (he describes approximately 85–90% still affected), and he says gastrointestinal symptoms also showed persistence rather than resolution.
His framework: inflammation and intestinal barrier patterns in long COVID
Dr. Nemechek connects long COVID symptom persistence to inflammation. He notes that in his other videos, he has discussed “a whole other line of work” indicating that long COVID patients can have high levels of inflammation and that they may be “leaking it” due to a particular pattern of intestinal barrier dysfunction (“leaky gut”).
In the video, he contrasts:
- Normal intestinal barrier appearance (he describes it as “nothing leaks through”).
- SIBO-associated leakage (he describes leakage “through the middle,” and mentions he has other videos on SIBO).
- COVID-associated barrier changes (he describes this as looking different, where “cells die and leave this gap”).
Within this framework, he presents intestinal barrier injury as a plausible contributor to ongoing inflammatory stress in long COVID, as he describes it.
What he says he does clinically: glutamine for 6 weeks for the barrier pattern he describes
Dr. Nemechek states that this COVID-associated intestinal barrier pattern can be treated successfully with a six-week course of glutamine. He describes glutamine as an amino acid and characterizes it as inexpensive and safe, stating it can be purchased through common retailers. (The video does not provide dosing details; only the duration is mentioned.)
He frames this as a practical step to consider when a child is having persistent symptoms, in the context of the intestinal barrier pattern he describes.
When SIBO may enter the picture (as described in the video)
Dr. Nemechek also discusses a second issue he says can occur over time. He notes that, based on adult data, after six months of COVID with ongoing long symptoms, a large number of adults begin to “trigger SIBO on top of it.” In his clinical interpretation, that may mean that some patients ultimately require addressing both the COVID-associated barrier pattern and SIBO.
Because he specifies this observation as adult data in the video, he does not explicitly claim the same timing or prevalence in children, but he raises it as a related clinical consideration in the broader long COVID landscape he is describing.
His brief prevention notes: vaccination and early treatment
Near the end of the video, Dr. Nemechek makes two brief points:
- He states that vaccines lessen the likelihood of long COVID.
- He also states that if a child is old enough, treatment with anti-COVID antibiotics decreases the chance of long COVID occurring.
The video does not specify particular products, timing, or eligibility criteria beyond “old enough,” and it does not provide dosing or protocol details.
Medical disclaimer
Want to Learn More About POTS and Autonomic Dysfunction?
Download Dr. Nemechek’s free POTS/PANS/PANDAS eBook for a deeper explanation of autonomic dysfunction, inflammation, and recovery.
This content is for educational purposes only and is not medical advice. Long COVID symptoms in children can overlap with many other conditions. If your child has persistent respiratory, neurological, cognitive, gastrointestinal, fatigue, or sleep symptoms after COVID, seek evaluation by a qualified clinician who can provide individualized assessment and care.
